1. Home
  2. BHVN vs PGNY Comparison

BHVN vs PGNY Comparison

Compare BHVN & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • PGNY
  • Stock Information
  • Founded
  • BHVN 2013
  • PGNY 2008
  • Country
  • BHVN United States
  • PGNY United States
  • Employees
  • BHVN N/A
  • PGNY N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • PGNY Misc Health and Biotechnology Services
  • Sector
  • BHVN Health Care
  • PGNY Health Care
  • Exchange
  • BHVN Nasdaq
  • PGNY Nasdaq
  • Market Cap
  • BHVN 1.9B
  • PGNY 1.8B
  • IPO Year
  • BHVN 2017
  • PGNY 2019
  • Fundamental
  • Price
  • BHVN $20.24
  • PGNY $21.19
  • Analyst Decision
  • BHVN Strong Buy
  • PGNY Buy
  • Analyst Count
  • BHVN 14
  • PGNY 9
  • Target Price
  • BHVN $62.92
  • PGNY $22.71
  • AVG Volume (30 Days)
  • BHVN 2.2M
  • PGNY 1.0M
  • Earning Date
  • BHVN 05-16-2025
  • PGNY 05-08-2025
  • Dividend Yield
  • BHVN N/A
  • PGNY N/A
  • EPS Growth
  • BHVN N/A
  • PGNY N/A
  • EPS
  • BHVN N/A
  • PGNY 0.57
  • Revenue
  • BHVN N/A
  • PGNY $1,213,181,000.00
  • Revenue This Year
  • BHVN N/A
  • PGNY $5.72
  • Revenue Next Year
  • BHVN $65.26
  • PGNY $11.43
  • P/E Ratio
  • BHVN N/A
  • PGNY $37.42
  • Revenue Growth
  • BHVN N/A
  • PGNY 9.46
  • 52 Week Low
  • BHVN $15.79
  • PGNY $13.39
  • 52 Week High
  • BHVN $55.70
  • PGNY $33.84
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 43.79
  • PGNY 37.05
  • Support Level
  • BHVN $18.75
  • PGNY $22.73
  • Resistance Level
  • BHVN $24.06
  • PGNY $23.77
  • Average True Range (ATR)
  • BHVN 2.00
  • PGNY 0.71
  • MACD
  • BHVN 0.21
  • PGNY -0.07
  • Stochastic Oscillator
  • BHVN 42.39
  • PGNY 24.56

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About PGNY Progyny Inc.

Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.

Share on Social Networks: